Abstract
Biomedical research has traditionally been slow and incremental, but the COVID-19 pandemic prompted a rapid break from this standard. The cornerstones of health research funding – gradual change and risk aversion – went out the window as the global medical community turned its attention to finding treatments and vaccines for COVID as fast as possible.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
